Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
242.59
+2.19 (0.91%)
At close: Mar 9, 2026, 4:00 PM EDT
242.79
+0.20 (0.08%)
After-hours: Mar 9, 2026, 5:20 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21 Apr '21 Jan '21 Sep '20 Jun '20 Mar '20
Innovative Medicine Revenue
15.76B
Innovative Medicine Revenue Growth
9.98%
MedTech Revenue
8.80B
MedTech Revenue Growth
7.49%
Revenue (Other)
-285.50M
Revenue (Total)
24.28B
Revenue (Total) Growth
7.81%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21 Apr '21 Jan '21 Sep '20 Jun '20 Mar '20
United States Revenue
14.20B
United States Revenue Growth
7.51%
Europe Revenue
5.60B
Europe Revenue Growth
13.76%
Western Hemisphere ex-US Revenue
1.27B
Western Hemisphere ex-US Revenue Growth
11.98%
Asia Pacific, Africa Revenue
3.50B
Asia Pacific, Africa Revenue Growth
7.36%
Revenue (Other)
-285.50M
Revenue (Total)
24.28B
Revenue (Total) Growth
7.81%

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21 Apr '21 Jan '21 Sep '20 Jun '20 Mar '20
Innovative Medicine Income Before Tax
5.06B
Innovative Medicine Income Before Tax Growth
26.17%
MedTech Income Before Tax
201.00M
MedTech Income Before Tax Growth
179.17%
Updated Jan 21, 2026. Data Source: Fiscal.ai.